{"id":358112,"date":"2019-04-22T03:20:03","date_gmt":"2019-04-22T03:20:03","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=358112"},"modified":"2019-04-22T03:20:03","modified_gmt":"2019-04-22T03:20:03","slug":"healthcare-nanotechnology-market-global-industry-analysis-size-share-growth-trends-and-forecast-2019-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/healthcare-nanotechnology-market-global-industry-analysis-size-share-growth-trends-and-forecast-2019-2024_358112.html","title":{"rendered":"Healthcare Nanotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2024"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Healthcare Nanotechnology”<\/div>\n<\/div>\n<\/div>\n
This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.<\/div>\n

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.<\/p>\n

Nanotechnology<\/strong> <\/a>is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.<\/p>\n

The classification of Healthcare Nanotechnology includes Nanomedicine, Nano Medical Devices, Nano Diagnosis and Other product. And the sales proportion of Nanomedicine in 2017 is about 86.5%, and the proportion is in increasing trend from 2013 to 2017.<\/p>\n

According to this study, over the next five years the Healthcare Nanotechnology market will register a 9.7% CAGR in terms of revenue, the global market size will reach US$ 255500 million by 2024, from US$ 160800 million in 2019. In particular, this report presents the global revenue market share of key companies in Healthcare Nanotechnology business, shared in Chapter 3.<\/p>\n

This report presents a comprehensive overview, market shares and growth opportunities of Healthcare Nanotechnology market by product type, application, key companies and key regions.<\/p>\n

This study considers the Healthcare Nanotechnology value generated from the sales of the following segments:<\/p>\n

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Nanomedicine
Nano Medical Devices
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Anticancer
CNS Product
Anti-infective
Other<\/p>\n

Request a Free Sample Report <\/span>@<\/strong>  https:\/\/www.wiseguyreports.com\/sample-request\/3702298-global-healthcare-nanotechnology-market-growth-status-and-outlook-2019-2024<\/a><\/p>\n

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries<\/p>\n

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor\/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
Smith & Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Shire
Ipsen
Endo International<\/p>\n

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.<\/p>\n

Research objectives
To study and analyze the global Healthcare Nanotechnology market size by key regions\/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Healthcare Nanotechnology market by identifying its various subsegments.
Focuses on the key global Healthcare Nanotechnology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Healthcare Nanotechnology with respect to individual growth trends, future prospects, and their contribution to the total market.<\/p>\n

Table of Contents<\/strong><\/p>\n

2019-2024 Global Healthcare Nanotechnology Market Report (Status and Outlook)<\/strong><\/p>\n

1 Scope of the Report<\/strong>
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered<\/p>\n

2 Executive Summary<\/strong>
2.1 World Market Overview
2.1.1 Global Healthcare Nanotechnology Market Size 2014-2024
2.1.2 Healthcare Nanotechnology Market Size CAGR by Region
2.2 Healthcare Nanotechnology Segment by Type
2.2.1 Nanomedicine
2.2.2 Nano Medical Devices
2.2.3 Nano Diagnosis
2.2.4 Other
2.3 Healthcare Nanotechnology Market Size by Type
2.3.1 Global Healthcare Nanotechnology Market Size Market Share by Type (2014-2019)
2.3.2 Global Healthcare Nanotechnology Market Size Growth Rate by Type (2014-2019)
2.4 Healthcare Nanotechnology Segment by Application
2.4.1 Anticancer
2.4.2 CNS Product
2.4.3 Anti-infective
2.4.4 Other
2.5 Healthcare Nanotechnology Market Size by Application
2.5.1 Global Healthcare Nanotechnology Market Size Market Share by Application (2014-2019)
2.5.2 Global Healthcare Nanotechnology Market Size Growth Rate by Application (2014-2019)<\/p>\n

3 Global Healthcare Nanotechnology by Players<\/strong>
3.1 Global Healthcare Nanotechnology Market Size Market Share by Players
3.1.1 Global Healthcare Nanotechnology Market Size by Players (2017-2019)
3.1.2 Global Healthcare Nanotechnology Market Size Market Share by Players (2017-2019)
3.2 Global Healthcare Nanotechnology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion<\/p>\n

………..<\/p>\n

11 Key Players Analysis<\/strong>
11.1 Amgen<\/strong>
11.1.1 Company Details
11.1.2 Healthcare Nanotechnology Product Offered
11.1.3 Amgen Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Amgen News
11.2 Teva Pharmaceuticals<\/strong>
11.2.1 Company Details
11.2.2 Healthcare Nanotechnology Product Offered
11.2.3 Teva Pharmaceuticals Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Teva Pharmaceuticals News
11.3 Abbott<\/strong>
11.3.1 Company Details
11.3.2 Healthcare Nanotechnology Product Offered
11.3.3 Abbott Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Abbott News
11.4 UCB<\/strong>
11.4.1 Company Details
11.4.2 Healthcare Nanotechnology Product Offered
11.4.3 UCB Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 UCB News
11.5 Roche<\/strong>
11.5.1 Company Details
11.5.2 Healthcare Nanotechnology Product Offered
11.5.3 Roche Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Roche News
11.6 Celgene<\/strong>
11.6.1 Company Details
11.6.2 Healthcare Nanotechnology Product Offered
11.6.3 Celgene Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Celgene News
11.7 Sanofi<\/strong>
11.7.1 Company Details
11.7.2 Healthcare Nanotechnology Product Offered
11.7.3 Sanofi Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Sanofi News
11.8 Merck & Co<\/strong>
11.8.1 Company Details
11.8.2 Healthcare Nanotechnology Product Offered
11.8.3 Merck & Co Healthcare Nanotechnology Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Merck & Co News<\/p>\n

……Continued<\/strong><\/p>\n

Make an enquiry of this Report @<\/strong> https:\/\/www.wiseguyreports.com\/enquiry\/3702298-global-healthcare-nanotechnology-market-growth-status-and-outlook-2019-2024<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com<\/a>
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.com<\/a><\/p>\n

 <\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Healthcare Nanotechnology” This report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. It is defined as the study of controlling, manipulating and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-358112","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/358112","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=358112"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/358112\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=358112"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=358112"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=358112"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}